Literature DB >> 28419211

The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice.

Rachel J Fenske1,2, Mark T Cadena2,3, Quincy E Harenda4, Haley N Wienkes2,3, Kathryn Carbajal2,3, Michael D Schaid1,2, Erin Laundre2,3, Allison L Brill2,3, Nathan A Truchan2,3, Harpreet Brar2,3, Jaclyn Wisinski1,2,3, Jinjin Cai5,6, Timothy E Graham5,6, Feyza Engin3,4, Michelle E Kimple1,2,3,7.   

Abstract

The α-subunit of the heterotrimeric Gz protein, Gαz, promotes β-cell death and inhibits β-cell replication when pancreatic islets are challenged by stressors. Thus, we hypothesized that loss of Gαz protein would preserve functional β-cell mass in the nonobese diabetic (NOD) model, protecting from overt diabetes. We saw that protection from diabetes was robust and durable up to 35 weeks of age in Gαz knockout mice. By 17 weeks of age, Gαz-null NOD mice had significantly higher diabetes-free survival than wild-type littermates. Islets from these mice had reduced markers of proinflammatory immune cell infiltration on both the histological and transcript levels and secreted more insulin in response to glucose. Further analyses of pancreas sections revealed significantly fewer terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL)-positive β-cells in Gαz-null islets despite similar immune infiltration in control mice. Islets from Gαz-null mice also exhibited a higher percentage of Ki-67-positive β-cells, a measure of proliferation, even in the presence of immune infiltration. Finally, β-cell-specific Gαz-null mice phenocopy whole-body Gαz-null mice in their protection from developing hyperglycemia after streptozotocin administration, supporting a β-cell-centric role for Gαz in diabetes pathophysiology. We propose that Gαz plays a key role in β-cell signaling that becomes dysfunctional in the type 1 diabetes setting, accelerating the death of β-cells, which promotes further accumulation of immune cells in the pancreatic islets, and inhibiting a restorative proliferative response.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28419211      PMCID: PMC5460933          DOI: 10.1210/en.2016-1700

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  47 in total

Review 1.  beta-Cell death during progression to diabetes.

Authors:  D Mathis; L Vence; C Benoist
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 2.  The NOD mouse.

Authors:  J F Bach; D Mathis
Journal:  Res Immunol       Date:  1997-06

Review 3.  Insulin-dependent diabetes mellitus.

Authors:  R Tisch; H McDevitt
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

4.  Apoptosis of autoreactive CD8 lymphocytes as a potential mechanism for the abrogation of type 1 diabetes by islet-specific TNF-alpha expression at a time when the autoimmune process is already ongoing.

Authors:  Urs Christen; Matthias G Von Herrath
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

5.  Preferential involvement of Go and Gz proteins in mediating rat natural killer cell lysis of allogeneic and tumor target cells.

Authors:  A A Maghazachi; A Al-Aoukaty; C Naper; K M Torgersen; B Rolstad
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

Review 6.  Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer.

Authors:  A A Maghazachi; A Al-Aoukaty
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

7.  Galphaz negatively regulates insulin secretion and glucose clearance.

Authors:  Michelle E Kimple; Jamie W Joseph; Candice L Bailey; Patrick T Fueger; Ian A Hendry; Christopher B Newgard; Patrick J Casey
Journal:  J Biol Chem       Date:  2007-12-20       Impact factor: 5.157

8.  Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.

Authors:  Alex Rabinovitch; Wilma L Suarez-Pinzon
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

9.  A single-islet microplate assay to measure mouse and human islet insulin secretion.

Authors:  Nathan A Truchan; Harpreet K Brar; Shannon J Gallagher; Joshua C Neuman; Michelle E Kimple
Journal:  Islets       Date:  2015       Impact factor: 2.694

10.  The induction of tolerance by dendritic cells that have captured apoptotic cells.

Authors:  R M Steinman; S Turley; I Mellman; K Inaba
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

View more
  8 in total

1.  Free fatty acid receptor 3 differentially contributes to β-cell compensation under high-fat diet and streptozotocin stress.

Authors:  Medha Priyadarshini; Connor Cole; Gautham Oroskar; Anton E Ludvik; Barton Wicksteed; Congcong He; Brian T Layden
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-02-19       Impact factor: 3.619

Review 2.  Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.

Authors:  Rachel J Fenske; Michelle E Kimple
Journal:  Exp Biol Med (Maywood)       Date:  2018-03-04

3.  Human Islet Expression Levels of Prostaglandin E2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity.

Authors:  Nathan A Truchan; Rachel J Fenske; Harpreet K Sandhu; Alicia M Weeks; Chinmai Patibandla; Benjamin Wancewicz; Samantha Pabich; Austin Reuter; Jeffrey M Harrington; Allison L Brill; Darby C Peter; Randall Nall; Michael Daniels; Margaret Punt; Cecilia E Kaiser; Elizabeth D Cox; Ying Ge; Dawn B Davis; Michelle E Kimple
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-16

Review 4.  Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass.

Authors:  Karin J Bosma; Cecilia E Kaiser; Michelle E Kimple; Maureen Gannon
Journal:  Metabolites       Date:  2022-04-12

5.  Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes.

Authors:  Annie R Piñeros; Abhishek Kulkarni; Hongyu Gao; Kara S Orr; Lindsey Glenn; Fei Huang; Yunlong Liu; Maureen Gannon; Farooq Syed; Wenting Wu; Cara M Anderson; Carmella Evans-Molina; Marcia McDuffie; Jerry L Nadler; Margaret A Morris; Raghavendra G Mirmira; Sarah A Tersey
Journal:  Cell Rep       Date:  2022-06-28       Impact factor: 9.995

6.  Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance.

Authors:  Jaclyn A Wisinski; Austin Reuter; Darby C Peter; Michael D Schaid; Rachel J Fenske; Michelle E Kimple
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-07-06       Impact factor: 4.310

7.  Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion.

Authors:  Harpreet K Sandhu; Joshua C Neuman; Michael D Schaid; Sarah E Davis; Kelsey M Connors; Romith Challa; Erin Guthery; Rachel J Fenske; Chinmai Patibandla; Richard M Breyer; Michelle E Kimple
Journal:  Pharmacol Res Perspect       Date:  2021-04

8.  OZITX, a pertussis toxin-like protein for occluding inhibitory G protein signalling including Gαz.

Authors:  Alastair C Keen; Maria Hauge Pedersen; Laura Lemel; Daniel J Scott; Meritxell Canals; Dene R Littler; Travis Beddoe; Yuki Ono; Lei Shi; Asuka Inoue; Jonathan A Javitch; J Robert Lane
Journal:  Commun Biol       Date:  2022-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.